The Merit WRAPSODY Central Feasibility Study

NCT04541576 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-04-20

No results posted yet for this study

Summary

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit in the thoracic central veins

Conditions

  • Venous Stenosis
  • Venous Occlusion

Interventions

DEVICE

Merit WRAPSODY Endovascular Stent Graft

Target lesion treated with stent graft placement

Sponsors & Collaborators

  • ClinLogix. LLC

    collaborator INDUSTRY
  • Merit Medical Systems, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-07-31
Completion
2024-02-29
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04541576 on ClinicalTrials.gov